410 related articles for article (PubMed ID: 21562838)
21. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
22. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
24. Bilateral synchronous breast carcinomas followed by a metastasis to the gallbladder: a case report.
Zagouri F; Sergentanis TN; Koulocheri D; Nonni A; Bousiotou A; Domeyer P; Michalopoulos NV; Dardamanis D; Konstadoulakis MM; Zografos GC
World J Surg Oncol; 2007 Sep; 5():101. PubMed ID: 17848197
[TBL] [Abstract][Full Text] [Related]
25. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Pregnancy-Associated Breast Cancer.
Labriola B
J Adv Pract Oncol; 2019; 10(7):692-700. PubMed ID: 33391853
[TBL] [Abstract][Full Text] [Related]
27. Case 242: Radiation-induced Angiosarcoma.
Disharoon M; Kozlowski KF; Kaniowski JM
Radiology; 2017 Jun; 283(3):909-916. PubMed ID: 28514220
[TBL] [Abstract][Full Text] [Related]
28. Current perspectives of treatment of ductal carcinoma in situ.
Estévez LG; Alvarez I; Seguí MÁ; Muñoz M; Margelí M; Miró C; Rubio C; Lluch A; Tusquets I
Cancer Treat Rev; 2010 Nov; 36(7):507-17. PubMed ID: 20462701
[TBL] [Abstract][Full Text] [Related]
29. The role of sentinel lymph node biopsy in the management of breast cancer.
Khan A; Vohra P; Quinlan RF
Indian J Pathol Microbiol; 2007 Apr; 50(2):261-9. PubMed ID: 17883042
[TBL] [Abstract][Full Text] [Related]
30. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.
Barnes NL; Dimopoulos N; Williams KE; Howe M; Bundred NJ
Eur J Surg Oncol; 2014 Mar; 40(3):249-54. PubMed ID: 24433818
[TBL] [Abstract][Full Text] [Related]
31. Atypical medullary carcinoma of the breast with cartilaginous metaplasia in a patient with a BRCA1 germline mutation.
Ashida A; Fukutomi T; Tsuda H; Akashi-Tanaka S; Ushijima T
Jpn J Clin Oncol; 2000 Jan; 30(1):30-2. PubMed ID: 10770566
[TBL] [Abstract][Full Text] [Related]
32. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
34. In situ ductal carcinoma of the breast--analysis of clinical presentation and outcome in 156 consecutive cases.
Ciatto S; Grazzini G; Iossa A; Del Turco MR; Bravetti P; Cataliotti L; Cardona G; Bianchi S
Eur J Surg Oncol; 1990 Jun; 16(3):220-4. PubMed ID: 2161353
[TBL] [Abstract][Full Text] [Related]
35. [Complete response of advanced breast cancer with lymph node metastases to nab-paclitaxel therapy-report of a case].
Hara Y; Sakurai K; Enomoto K; Matsumoto K; Ueda Y; Hagiwara M; Waga E; Nagashima S; Tani M; Amano S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2080-2. PubMed ID: 23267983
[TBL] [Abstract][Full Text] [Related]
36. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
[TBL] [Abstract][Full Text] [Related]
37. HER-2 overexpression is not associated with increased ipsilateral breast tumor recurrence in DCIS treated with breast-conserving surgery followed by radiotherapy.
Noh JM; Lee J; Choi DH; Cho EY; Huh SJ; Park W; Nam SJ; Lee JE; Kil WH
Breast; 2013 Oct; 22(5):894-7. PubMed ID: 23643805
[TBL] [Abstract][Full Text] [Related]
38. Recent advances and current controversies in the management of DCIS of the breast.
Sakorafas GH; Farley DR; Peros G
Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
[TBL] [Abstract][Full Text] [Related]
39. MRI accurately depicts underlying DCIS in a patient with Paget's disease of the breast without palpable mass and mammography findings.
Amano G; Yajima M; Moroboshi Y; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2005 Mar; 35(3):149-53. PubMed ID: 15741305
[TBL] [Abstract][Full Text] [Related]
40. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
